HC Wainwright Trims Black Diamond Therapeutics (NASDAQ:BDTX) Target Price to $11.00
Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) had its target price trimmed by HC Wainwright from $12.00 to $11.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Black Diamond Therapeutics’ Q1 2025 earnings at ($0.46) EPS, Q2 2025 […]
More Stories
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO) Stock Price Crosses Above 200 Day Moving Average – Here’s Why
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO – Get Free Report) shares crossed above its 200-day moving average during trading on...
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO) Share Price Pass Above Two Hundred Day Moving Average – Should You Sell?
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO – Get Free Report) crossed above its 200-day moving average during...
Cheetah Canyon Resources (CVE:CHTA) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Shares of Cheetah Canyon Resources (CVE:CHTA – Get Free Report) crossed below its 200-day moving average during trading on Thursday...
ProShares K-1 Free Crude Oil ETF (BATS:OILK) Share Price Cross Below 200-Day Moving Average – Here’s What Happened
ProShares K-1 Free Crude Oil ETF (BATS:OILK – Get Free Report) shares passed below its 200-day moving average during trading...
Euclid Capital Growth ETF (BATS:EUCG) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Shares of Euclid Capital Growth ETF (BATS:EUCG – Get Free Report) passed above its 200-day moving average during trading on...
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Leelyn Smith LLC
Leelyn Smith LLC raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.6% during...